D
Arcus Biosciences, Inc. RCUS
$9.34 -$0.20-2.10%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

12/31/2024 09/30/2024
Revenue -45.83% 23.08%
Total Other Revenue -- --
Total Revenue -45.83% 23.08%
Cost of Revenue -17.89% 1,130.00%
Gross Profit 0.00% -358.62%
SG&A Expenses -6.67% 0.00%
Depreciation & Amortization -- --
Other Operating Expenses -- --
Total Operating Expenses -15.69% 5.52%
Operating Income 1.90% 0.94%
Income Before Tax -1.09% 1.08%
Income Tax Expenses -- --
Earnings from Continuing Operations -2.17% 1.08%
Earnings from Discontinued Operations -- --
Extraordinary Item & Accounting Change -- --
Minority Interest in Earnings -- --
Net Income -2.17% 1.08%
EBIT 1.90% 0.94%
EBITDA 2.91% 0.96%
EPS Basic -1.84% 1.40%
Normalized Basic EPS -0.76% 1.39%
EPS Diluted -1.84% 1.40%
Normalized Diluted EPS -0.76% 1.39%
Average Basic Shares Outstanding 0.33% 0.33%
Average Diluted Shares Outstanding 0.33% 0.33%
Dividend Per Share -- --
Payout Ratio -- --
Weiss Ratings